AI Rare Platform

​

Our approach to rare diseases therapy started from the Search & Match model, initially developed in 2001 by Mondobiotech's founders, and was honored with the WEF Technology Pioneer Award.

 

Today, MondoRare has advanced this groundbreaking model by integrating state-of-the-art AI technology. 

 

Our AI Rare platform enhances the accuracy and efficiency of identifying potential therapies, ensuring rapid progression to clinical application.